• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4657932)   Today's Articles (3972)   Subscriber (51251)
For: Ellis AL, Pan W, Yang G, Jones K, Chuang C, Whitelock JM, DeCarlo AA. Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1. BMC Biotechnol 2010;10:66. [PMID: 20828410 PMCID: PMC2944331 DOI: 10.1186/1472-6750-10-66] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2010] [Accepted: 09/09/2010] [Indexed: 11/16/2022]  Open
Number Cited by Other Article(s)
1
Lord MS, Ellis AL, Farrugia BL, Whitelock JM, Grenett H, Li C, O'Grady RL, DeCarlo AA. Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing. J Control Release 2017;250:48-61. [DOI: 10.1016/j.jconrel.2017.02.009] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Accepted: 02/07/2017] [Indexed: 12/21/2022]
2
Melrose J. Glycosaminoglycans in Wound Healing. ACTA ACUST UNITED AC 2016. [DOI: 10.4137/btri.s38670] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
3
Farrugia BL, Lord MS, Melrose J, Whitelock JM. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard? Molecules 2015;20:4254-76. [PMID: 25751786 PMCID: PMC6272578 DOI: 10.3390/molecules20034254] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 02/13/2015] [Accepted: 02/26/2015] [Indexed: 12/21/2022]  Open
4
Lord MS, Whitelock JM. Recombinant production of proteoglycans and their bioactive domains. FEBS J 2013;280:2490-510. [DOI: 10.1111/febs.12197] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2012] [Revised: 02/04/2013] [Accepted: 02/15/2013] [Indexed: 12/11/2022]
5
Weyers A, Linhardt RJ. Neoproteoglycans in tissue engineering. FEBS J 2013;280:2511-22. [PMID: 23399318 DOI: 10.1111/febs.12187] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2012] [Revised: 02/01/2013] [Accepted: 02/06/2013] [Indexed: 01/12/2023]
6
Melrose J, Smith MM, Smith SM, Ravi V, Young AA, Dart AJ, Sonnabend DH, Little CB. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy. Tissue Cell 2012;45:77-82. [PMID: 23245384 DOI: 10.1016/j.tice.2012.10.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2012] [Revised: 10/05/2012] [Accepted: 10/07/2012] [Indexed: 01/01/2023]
7
Decarlo AA, Belousova M, Ellis AL, Petersen D, Grenett H, Hardigan P, O'Grady R, Lord M, Whitelock JM. Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis. BMC Biotechnol 2012;12:60. [PMID: 22967000 PMCID: PMC3485628 DOI: 10.1186/1472-6750-12-60] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2012] [Accepted: 08/08/2012] [Indexed: 11/17/2022]  Open
8
Ma K, Huang Z, Ma J, Shao L, Wang H, Wang Y. Perlecan and synaptophysin changes in denervated skeletal muscle. Neural Regen Res 2012;7:1293-8. [PMID: 25657658 PMCID: PMC4308798 DOI: 10.3969/j.issn.1673-5374.2012.17.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2012] [Accepted: 04/23/2012] [Indexed: 11/18/2022]  Open
9
Whitelock J, Melrose J. Heparan sulfate proteoglycans in healthy and diseased systems. WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE 2011;3:739-51. [PMID: 21462353 DOI: 10.1002/wsbm.149] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
10
Muthusamy A, Cooper CR, Gomes RR. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells. BMC BIOCHEMISTRY 2010;11:43. [PMID: 21047416 PMCID: PMC2987766 DOI: 10.1186/1471-2091-11-43] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/30/2010] [Accepted: 11/03/2010] [Indexed: 01/13/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA